Selective peroxisome proliferator-activated receptor delta isosteric selenium agonists as potent anti-atherogenic agents in vivo
- Authors
- Chin, Jungwook; Hong, Jun Young; Lee, Jaehwan; Hwang, Hoosang; Ko, Hyunsil; Choi, Hyukjae; Hahn, Dongyup; Ko, Jaeyoung; Nam, Sang-Jip; Tak, Jungae; Ham, Jungyeob; Kang, Heonjoong
- Issue Date
- 2010-12-15
- Publisher
- Pergamon Press Ltd.
- Citation
- Bioorganic & Medicinal Chemistry Letters, v.20, no.24, pp.7239 - 7242
- Abstract
- We report the synthesis and in vivo activity of a novel anti-atherogenic agent, isosteric selenium PPAR delta-selective ligand. This ligand did not cause significant body or liver weight changes and did not have obvious adverse effects on intestinal polyp formation. Our overall results clearly demonstrate that PPAR delta is a viable drug candidate for targeting and treating atherosclerosis. (C) 2010 Elsevier Ltd. All rights reserved.
- Keywords
- PPAR-DELTA; MOLECULAR MODIFICATION; ATHEROSCLEROSIS; CHOLESTEROL; SULFIDES; BIOISOSTERISM; BETA/DELTA; MODELS; HEART; MICE; PPAR-DELTA; MOLECULAR MODIFICATION; ATHEROSCLEROSIS; CHOLESTEROL; SULFIDES; BIOISOSTERISM; BETA/DELTA; MODELS; HEART; MICE; PPAR delta-selective ligand; Anti-atherogenic agents; Intestinal polyp formation
- ISSN
- 0960-894X
- URI
- https://pubs.kist.re.kr/handle/201004/130824
- DOI
- 10.1016/j.bmcl.2010.10.103
- Appears in Collections:
- KIST Article > 2010
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.